1. Home
  2. ITRN vs AKBA Comparison

ITRN vs AKBA Comparison

Compare ITRN & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRN
  • AKBA
  • Stock Information
  • Founded
  • ITRN 1994
  • AKBA 2007
  • Country
  • ITRN Israel
  • AKBA United States
  • Employees
  • ITRN N/A
  • AKBA N/A
  • Industry
  • ITRN Electronic Components
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITRN Technology
  • AKBA Health Care
  • Exchange
  • ITRN Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • ITRN 653.7M
  • AKBA 669.7M
  • IPO Year
  • ITRN 2005
  • AKBA 2014
  • Fundamental
  • Price
  • ITRN $38.09
  • AKBA $3.03
  • Analyst Decision
  • ITRN Buy
  • AKBA Strong Buy
  • Analyst Count
  • ITRN 1
  • AKBA 4
  • Target Price
  • ITRN $50.00
  • AKBA $6.63
  • AVG Volume (30 Days)
  • ITRN 80.9K
  • AKBA 5.0M
  • Earning Date
  • ITRN 05-28-2025
  • AKBA 05-08-2025
  • Dividend Yield
  • ITRN 5.25%
  • AKBA N/A
  • EPS Growth
  • ITRN 10.62
  • AKBA N/A
  • EPS
  • ITRN 2.77
  • AKBA N/A
  • Revenue
  • ITRN $337,686,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • ITRN $11.52
  • AKBA $21.58
  • Revenue Next Year
  • ITRN $9.29
  • AKBA $47.69
  • P/E Ratio
  • ITRN $13.76
  • AKBA N/A
  • Revenue Growth
  • ITRN 3.73
  • AKBA N/A
  • 52 Week Low
  • ITRN $24.12
  • AKBA $0.80
  • 52 Week High
  • ITRN $45.43
  • AKBA $3.14
  • Technical
  • Relative Strength Index (RSI)
  • ITRN 58.13
  • AKBA 71.68
  • Support Level
  • ITRN $35.06
  • AKBA $2.76
  • Resistance Level
  • ITRN $39.37
  • AKBA $3.14
  • Average True Range (ATR)
  • ITRN 1.22
  • AKBA 0.15
  • MACD
  • ITRN 0.02
  • AKBA 0.02
  • Stochastic Oscillator
  • ITRN 70.19
  • AKBA 86.08

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products. The Telematics services segment consists of regionally- based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: